Articles |
From the Department of Medicine (M.M.P., C.S.L., S.Y.), Division of Cardiovascular Disease; the Department of Physiology and Biophysics (G.R.H.); and the Department of Pathology (P.G.A.), Division of Molecular/Cellular Pathology; University of Alabama at Birmingham.
Correspondence to Dr M.M. Pike, Department of Medicine, Division of Cardiovascular Disease, 703 S 19th Street, ZRB 308, Birmingham, AL 35294-0007.
| Abstract |
|---|
|
|
|---|
300% of control) and increased HEP depletion. A delayed
postischemic functional recovery occurred in VF hearts,
which correlated temporally with the recovery of
Na+i. In conclusion, alterations in
Na+i were associated with spontaneous VF
transitions, consistent with involvement of excess
Na+i accumulation in VF initiation and
maintenance and with previously reported alterations in
Ca2+i with VF. Hypertrophied band hearts
exhibited enhanced susceptibility to ischemia-induced VF,
possibly linked to a lower HEP reserve.
Key Words: ventricular fibrillation intracellular Na+ ischemia nuclear magnetic resonance cardiac hypertrophy
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
Pharmacological Interventions
The Na+-H+ exchange
inhibitor HMA was dissolved in perfusate (617 µmol/L
stock) and infused into the aortic line just above the heart (final
concentration, 10 µmol/L) for 15 minutes before ischemia in
subgroups of sham and band (sham-HMA and band-HMA). Infusion was
continued during ischemia (same final concentration) and was
terminated on reperfusion.
NMR Spectroscopy
The 23Na and 31P NMR spectra were
obtained with a Bruker AM-360 spectrometer with a homebuilt
temperature-controlled switchable NMR probe, which could collect
spectra from both nuclei without retuning. Data collection alternated
automatically between the collection of 23Na (1 minute) and
31P (2 minutes) NMR spectra. The 23Na NMR
spectral acquisition parameters and the signal area
measurement methodology were as previously described.23
Gaussian multiplication of the 23Na free induction decays
was used for signal-to-noise noise improvement and (minimal) resolution
enhancement; the NMR1 GM subroutine was used
with parameters G1=0, G2=20, and G3=0.1 (NMR1
software, New Methods Research, Inc).
NMR-visible Na+i was quantified in the experiments by comparison with spectra obtained after the experiment from an NaCl solution contained within a heart-sized glass sphere. However, for all protocols, Na+i was reported as percent control to focus on changes in the Na+i rather than absolute differences and to reduce experimental variability resulting from quantification errors. Also, the reporting of Na+i content requires assumptions concerning the 23Na NMR visibility, which has not been directly determined for these conditions. Comparison between the experimental groups using percent control is valid because absolute control values for sham and band (19.1±0.5 and 18.1±1.0 µmol NMR visible Na+i per g dry wt, respectively) were not significantly different. Also, no significant differences were found between subgroups of sham or of band.
The 31P NMR spectral acquisition parameters, plotting parameters, and signal area measurement methodology were as previously described.23 Phosphorus metabolites were quantified by comparing the signal areas with those from the 100 mmol/L PPA standard solution in the left ventricular balloon; linear regression was performed on signal areas from several spectra obtained at the end of the experiment after incremental balloon volume increases. For each experiment, a fully relaxed spectrum, using a recycle time of 10 seconds, was acquired before the control period. From comparison with the control spectra, empirical saturation factors for the various resonances were derived: 1.58, 1.40, and 1.17 for PPA, PCr, and ATP, respectively. Low control Pi levels necessitated calculating a value (1.10) from the reported spin-lattice relaxation time (T1) for Pi in rat heart31 by using Equation 17 from Becker et al.32 pHi was calculated from the shift of the Pi resonance.33
Lactate Measurements
Lactate efflux (in micromoles per minute per gram dry weight)
was measured by analysis of the coronary effluent
(assay kit No. 826, Sigma Chemical Co). During ischemia, the
entire effluent was collected at 17-minute intervals, taking care to
remove coronary effluent remaining in the NMR tube by external
flushing. During reperfusion, the effluent was collected at 2, 3, 4, 5,
10, 15, 30, and 45 minutes of reperfusion.
Electrogram Measurements
Simultaneous electrogram and NMR measurements were
not possible because of the introduction of radiofrequency noise.
However, several sham (n=3) and band (n=3) hearts were perfused with
shift reagent perfusate exactly as described above without collecting
NMR data. Three bipolar plunge electrodes constructed of
polytetrafluoroethylene (Teflon)coated wire were placed in the
ventricular myocardium. By use of an Astromed
9500 multichannel recorder, multiple local electrograms were
simultaneously recorded from different positions on the
ventricles.
Statistics
Values were reported as mean±SEM. An NCSS software
package was used for statistical analysis. General linear
models ANOVA was generally used; paired t tests were also
used as indicated. Fishers exact test was used to compare the incidence
of VF between groups. Results were considered significant at
P<.05. To test VF predictability, the Number Cruncher
Statistical System (NCSS) discriminant analysis
routine was used as described.
| Results |
|---|
|
|
|---|
|
|
The percentage of all untreated sham hearts (n=24, including those used for NMR and electrogram measurements) exhibiting such contractile failure/VF during the ischemic period was 50%, a proportion significantly less than the 89% observed for untreated band hearts (n=18, P<.01). The mean ischemia times at which fibrillating sham (sham-VF) hearts and fibrillating band (band-VF) hearts went into VF were 35.8±2.3 and 29.8±2.1 minutes, respectively. Most interestingly, the preparations treated with HMA during ischemia, sham-HMA and band-HMA groups, all continued contracting throughout the protocol and did not exhibit VF, representing significantly lower incidences of VF than were observed in the untreated sham and band groups. This is consistent with previous reports that Na+-H+ inhibition reduces reperfusion arrhythmias.23 34 The mean heart dry weights, body weights, and heart dry weighttobody weight ratios were 0.213±0.004 g, 357±7 g, and 6.01±0.13x10-4, respectively, for the sham group and 0.281±0.008 g (P<.0001 versus sham), 320±10 g (P<.005 versus sham), and 8.92±0.28x10-4 (P<.0001 versus sham), respectively, for the band group. The data clearly indicate the development of substantial hypertrophy in band hearts. There were no significant differences or different trends evident between the sham or the band subgroups for these parameters (data not shown). To eliminate from the study hearts from animals that may have been banded ineffectively, band hearts were not included in the study if the total heart wet weighttobody weight ratio was lower than the mean value by more than 1 SD; only two of 29 band hearts were eliminated from the study in this fashion.
Table 1
summarizes LVDP during (pre-HMA) control and end
reperfusion for all sham and band subgroups on which NMR measurements
were obtained, including untreated hearts that contracted throughout
ischemia (sham-C, n=11; band-C, n=2), HMA-treated hearts
(sham-HMA, n=6; band-HMA, n=9), and hearts exhibiting contractile
failure/VF (sham-VF, n=10; band-VF, n=13). As expected, the band hearts
had significantly higher ventricular pressures than did the
sham hearts because of hypertrophy of the
ventricular wall. No significant differences were found
between the sham subgroups or between the band subgroups in either
control or end reperfusion LVDP. During reperfusion, a complete
functional recovery was observed in all hearts, confirming that the VF
was ischemia-induced. However, the recovery for the sham- and
band-VF hearts was delayed compared with the sham- and band-C and -HMA
groups. Steady contraction in the range of 10 mm Hg LVDP was
maintained in all band- and sham-C and -HMA groups during
ischemia, with diastolic tension remaining
relatively stable throughout the protocol. In contrast, between early
and late ischemia in sham-VF, diastolic tension
increased from 3±1 to 14±1 mm Hg. On reperfusion,
diastolic tension markedly increased to 47±6 mm Hg (at 2
minutes reperfusion). The mean diastolic tension gradually
decreased over the next 10 minutes, although in individual experiments
the decreases were invariably abrupt and associated with the restart of
contraction. The band-VF group also showed increasing
diastolic tension during ischemia (increased from
4±1 to 22±5 mm Hg), which also sharply increased to 53±10 mm Hg at
2 minutes of reperfusion before returning to the control level. The
LVDP values at the end of preischemic HMA infusion for
sham-HMA and band-HMA were 89±15 and 159±9 mm Hg, respectively,
values that were virtually unchanged from the pre-HMA control values
reported in Table 1
.
|
NMR Measurements
Fig 3A
displays 23Na NMR spectra
obtained from a sham-C heart during control and at end
ischemia. Note that the Tm(DOTP)5- shift reagent
affords excellent resolution of the Na+i
resonance even in the presence of the large extracellular
Na+ resonance, derived largely from the coronary
effluent surrounding the preparation. The frequency of the
Na+i and extracellular Na+
resonances as well as the area of the extracellular Na+
resonance were extraordinarily stable throughout the experiments. The
balloon reference signal area was similarly stable, but its frequency
exhibited instability and heterogeneity upon the
introduction of ischemia. Macroscopic geometry considerations
make the bulk magnetic susceptibility shift component of the balloon
resonance sensitive to the vascular changes that alter the shift
reagent content of the surrounding tissue.35 The figure
indicates an increase in the Na+i resonance
during ischemia to 144% of control, as was typical for the
contracting hearts. In Fig 3B
, analogous 23Na NMR spectra
are shown from a band-VF heart. In contrast to the heart depicted in
Fig 3A
, the spectra indicate a substantial increase in
Na+i to 350% of control, revealing that in the
fibrillating heart, Na+i homeostasis was
significantly altered. Fig 4
shows the interleaved
31P NMR spectra from the same two hearts shown in Fig 3
and
reveals that the fibrillating band-VF heart also indicated
substantially more depletion of PCr, ATP, and accumulation of
Pi than the contracting sham-C heart.
|
|
In Fig 5
, mean values of Na+i
and pHi are shown across time for the various experimental
groups. Consistent with the spectra in Fig 3
, the data indicate
that in the contracting groups Na+i increased
moderately during ischemia and then became relatively stable.
In contrast, Na+i increased to
300% of
control in the sham-VF and band-VF groups, a much greater increase
compared with their respective sham- and band-C and -HMA groups
(P<.005, end ischemia). Although the
pHi changes were not nearly as severe as are observed with
zero-flow ischemia models,23 the sham-VF and
band-VF groups also indicated greater decreases in pHi
compared with their respective sham- and band-C and -HMA contracting
groups (P<.05 at end ischemia, except for band-C). For the
sham-HMA and band-HMA groups, Na+i decreased
during the 15-minute preischemic loading period, decreasing
to 78±2% and 87±3% of the control value, respectively. Even during
early ischemia, Na+i in the HMA groups
was maintained at lower levels than in the VF groups. In the sham-HMA
group, HMA treatment attenuated Na+i
accumulation, even when compared with the sham-C group
(P<.05 versus sham-HMA at end ischemia). The
divergence of the cationic changes in the VF and contracting groups
became particularly marked during latter ischemia, when changes
in the VF groups accelerated. No differences were evident when
comparing sham groups with analogous band groups; the changes were all
remarkably similar. An essentially complete recovery of both
Na+i and pHi during reperfusion was
observed for all groups; at end reperfusion (pooled the final 10
minutes), Na+i in the band-VF group did remain
at
10% above control levels (P<.05). The HMA groups
tended to recover to levels below their respective control levels
(P<.05 for sham-HMA).
|
Fig 6
shows mean PCr, ATP, and Pi content
plotted across time for sham and band subgroups. There were no
significant differences in phosphorus metabolites between the sham or
the band subgroups during control conditions. However, the figure
indicates lower control levels of PCr in band compared with sham
groups. The PCr, ATP, and Pi for combined sham subgroups in
the control condition (before HMA) were as follows (µmol/g dry wt):
53.3±1.6, 29.2±1.0, and 1.9±0.5, respectively, and 39.8±2.0
(P<.0001 versus sham), 26.4±1.2 (P=.08 versus
sham), and 3.3±0.5 (P<.05 versus sham), respectively, for
combined band subgroups. During ischemia, greater PCr and ATP
depletion and Pi accumulation occurred in the sham-VF and
band-VF groups than in their respective sham- and band-C and -HMA
groups, particularly during latter ischemia (P<.05
at end ischemia). Deterioration of cellular energy in the sham-
or band-HMA and -C groups was moderate but not necessarily equal:
Pi accumulation was greater in the sham-HMA group than in
the sham-C group (P<.05 at end ischemia). In all
groups, PCr recovered completely during reperfusion. In contrast, ATP
remained significantly below control levels at end reperfusion (pooled
the final 10 minutes) in all groups and also was lower in VF groups
than in analogous contracting groups at that time (sham-VF versus
sham-C and sham-HMA, P<.005; band-VF versus band-HMA,
P<.05). In the VF groups, Pi remained
significantly above control levels at end reperfusion.
|
Fig 7
shows mean lactate efflux rates for sham and band
subgroups. Lactate efflux increased gradually throughout
ischemia to rather substantial levels, near 20 µmol/g dry wt
per minute. On reperfusion, lactate efflux increased transiently and
then rapidly decreased toward control levels. No significant
differences in lactate efflux were detected between any groups during
ischemia. However, during early reperfusion, lactate efflux
markedly increased for sham- and band-VF groups to levels much higher
than were observed in the sham- and band-C groups. There was also
evidence for elevated reperfusion lactate efflux in the HMA groups.
Calculation of total lactate efflux during the first 15 minutes of
reperfusion confirmed that reperfusion lactate efflux was greater in
the sham- and band-VF than in the sham- and band-C groups (µmol/g dry
wt): sham-VF, 135±25; sham-C, 53±13 (P=.012 versus
sham-VF); sham-HMA, 87±13; band-VF, 109±17; band-C, 28±19; and
band-HMA, 118±29. Both the combined sham- and band-VF groups
(P<.003) and the combined sham- and band-HMA groups
(P<.02) demonstrated greater total reperfusion lactate
efflux than the combined sham- and band-C groups.
|
Fig 8
shows sham-VF and band-VF
Na+i and pHi data obtained during
the ischemic period only that are plotted versus the time from
VF. Ischemia times vary at the onset of VF, so the observed
changes require careful interpretation. However, the plots reveal that
rapid Na+i and pHi changes started
to occur at the onset of VF. The abrupt change in the slopes indicates
that exactly at that time, net Na+ influx dramatically
increased and resulted in levels near 300% of control within a few
minutes. Panels B and D in Fig 8
indicate that these rapid changes were
paralleled by decreases in pHi, which decreased
from values near 7.0 before VF to values near 6.8 after 10 minutes of
VF. Table 2
indicates values of the
metabolic parameters 3 minutes before and 3
minutes after the onset of VF and reveals that rapid changes were also
occurring in energetic parameters. Although only 6 minutes
separated these time points, all of the cationic and energetic
parameters were found to be significantly different (paired
t test).
|
|
In addition to showing Na+i and pHi
data versus time from VF, Fig 8
also indicates data from the
contracting groups (sham- or band-C and -HMA) obtained during the
latter ischemic period; the data were referenced to
ischemia duration, but with the average time of VF initiation
in the analogous VF group taken as the zero time point. The data
illustrate the relative stability of Na+i and
pHi during latter ischemia in the contracting
groups. Comparison with VF groups clearly indicates that substantial
alteration of cation homeostasis occurs after VF and is not due to
ischemia alone but is largely due to the presence of sustained
ischemia-induced VF. However, the figure also suggests that
although not nearly as severe, alteration in cationic homeostasis
before the onset of VF in the VF groups was greater than that occurring
during ischemia in the contracting groups. The
Na+i levels 3 minutes before VF initiation in
the sham-VF and band-VF groups (see Table 2
) were higher than those in
their respective sham- and band-C and -HMA groups at 3 minutes before
the average time of VF (P<.001, excluding band-C). The
Na+i level for both VF groups was at 160% of
control. In contrast, it was 129±3% and 116±3% for sham-C and -HMA
groups, respectively, and 126±18% and 120±5% for band-C and -HMA
groups, respectively, indicating a Na+i
accumulation equal to or less than half of that observed in the VF
groups. A similar comparison with pHi indicated small but
measurable differences (P<.05, excluding band-C).
In addition to comparing data referenced to VF onset with that
referenced to ischemia duration, a rigorous analysis
was done comparing data obtained at the same duration of
ischemia. The 20-minute time point was chosen because it is a
substantial period of ischemia, the metabolic
parameters in the contracting groups were stabilizing, and
importantly, none of the hearts were in VF. Although the 20-minute time
point long preceded the average time of VF in both VF groups,
differences in certain metabolic parameters
were apparent between the VF and contracting groups. Notably, although
Na+i at 20 minutes did not approach the extreme
levels occurring after VF, Na+i was
significantly greater at 20 minutes in the sham-VF group (144±4%)
than in both the sham-C and sham-HMA groups (128±4% and 117±3%,
respectively; P<.005). Similarly, the mean
Na+i level in the band-VF group (148±3%)
increased significantly more at 20 minutes of ischemia than in
the band-C group (122±19%; P<.05) and the band-HMA group
(118±4%; P<.005). Consistent with Fig 8
, the data
indicate that Na+i accumulation in the
contracting groups was approximately half of that observed in the VF
groups. In the sham-VF group, ATP was significantly lower and the
Pi was higher than in the sham-C group. Statistical
differences in phosphorus metabolites were not detected between band-VF
and band-C groups. Interestingly, there were no significant differences
in any phosphorus metabolites detected between the VF and HMA subgroups
in both sham and band groups. Consistent with this observation
was that PCr and ATP were significantly lower and Pi was
higher in the sham-HMA group than in the sham-C group at the 20-minute
time point. Hence, the data suggest a relatively specific attenuation
of Na+i accumulation during ischemia in
band and sham groups with Na+-H+ exchange
inhibition; HMA did not offer any measurable protection from
high-energy phosphate depletion.
Data at the 20-minute ischemia time point were analyzed
further by discriminant analysis to determine the ability to
predict VF from the metabolic variables. This
statistical technique simultaneously considers a profile of
variables, thus improving predictive power by considering
variable interaction and patterns. The analysis models an
equation, which calculates the probability of a certain experimental
outcome (VF), based on the variables. Table 3
summarizes the results of this analysis. The
parameter PR is the percent improvement in classification
accuracy over random classification and is lower than (or equal for
PR=100%) the absolute classification accuracy; PR of 80% indicates
that 90% of the experiments were correctly classified. The F-PROB
values indicate the significance of the variable in the prediction,
with lower values indicating higher significance (range, 0 to 1). Table 3
summarizes VF prediction analyses using
Pi, PCr, ATP, pHi, and
Na+i (at 20 minutes of ischemia) with
three different group combinations: sham-VF versus sham-C, sham-VF
versus sham-HMA, and band-VF versus band-HMA. An analysis of
band-VF versus band-C alone was not possible because of the low
experimental number of band-C. Combined band and sham analyses
were not performed because they started with inherently different
energy patterns at control. The PR values indicated in the table
demonstrate excellent VF prediction from the metabolic
variables, and the F-PROB parameters indicate that
Na+i is clearly the most powerful VF predictor.
This is especially true for the analyses involving HMA groups,
which indicate 100% predictive accuracy and very low F-PROB values for
Na+i. The analyses were repeated after
removing Na+i or both
Na+i and pHi from consideration
(not shown). Interestingly, for the sham-VF versus sham-C groups,
prediction accuracy did not decrease; PR remained at
80%, and
Pi became the most significant variable. When VF
prediction was tested from individual variables alone,
Na+i gave the lowest F-PROB values, but
Na+i, Pi, and ATP
each still succeeded in predicting VF with a PR of 60% (other
variables,
30%). Contrasting results were obtained with sham-VF
versus sham-HMA and band-VF versus band-HMA groups. Removal of
Na+i from consideration resulted in low
prediction accuracy (PR,
30%). Only Na+i
could predict VF by itself, with by far the lowest F-PROB values and
with PR values of 88% and 62% for sham and band groups, respectively
(
30% for the other variables). Analyses that tested VF
prediction within all three sham groups and within all three band
groups were also performed. In these cases, prediction accuracy was
still high, and under all conditions, Na+i was
the only predictive variable; the inclusion of sham-HMA apparently
reduced the prediction significance of the energy variables within
the sham subgroups.
|
In addition to using the metabolic parameters
at 20 minutes of ischemia, extensive discriminant
analyses were performed using the control data. Little
predictive accuracy was found at that time, and PR remained
20% in
all cases. Additionally, dry weight, the dry weighttobody weight
ratio, and control LVDP were found to be poor predictors of VF within
sham or band groups. No combination of these variables with the
metabolic variables resulted in increased predictive
accuracy.
In comparing the functional and Na+i
reperfusion data in the VF groups, a significant correlation
(P<.0001) was found between the reperfusion time required
to reestablish paced contractions with an LVDP of
10 mm Hg
(Tfunc) and that required for Na+i
to decrease below 160% of control (TNa+), the
mean level at which VF was initiated (see Table 2
) during
ischemia. Linear regression was used to fit the following
function (in minutes):
Tfunc=0.94 · TNa++0.44;
R2=.62. Also of note is that the mean values for
these parameters were essentially identical in both VF
groups: mean Tfunc and mean TNa+
were 9.0±1.0 and 8.8±0.7 minutes, respectively, for the sham-VF group
and 7.6±1.3 and 8.0±1.2 minutes, respectively, for the band-VF group.
Consistent with this, an examination of the
Na+i levels in each heart using the
23Na NMR spectrum closest to the time of contractile
recovery indicated mean values of 148±8% and 159±10% for sham-VF
and band-VF groups, respectively.
| Discussion |
|---|
|
|
|---|
Prevention of VF via HMA was not likely to result from effects
unrelated to Na+-H+ inhibition. HMA is a
specific inhibitor, with a Ki (0.16
µmol/L) >500 times lower than that of amiloride.37
Unlike with amiloride, experiments using HMA can employ an effective
inhibitory concentration that is an order of magnitude
lower than the Ki reported for
Na+-Ca2+ exchange.37 The
lack of functional effects after 15 minutes of preischemic
perfusion with HMA argues against nonspecific effects, especially in
regard to direct effects on Ca2+i
handling. The lack of an effect on pHi during
ischemia is consistent with a previous report from our
laboratory23 and with other studies.25 38 39 40
This observation is likely to be related to the activity of alternative
H+ extrusion mechanisms such as lactate-H+
cotransport and CO2 efflux.40
Consistent with a previous study,23
Na+-H+ exchange inhibition succeeded in
reducing Na+i levels during low-flow
ischemia. This reduction was associated with prevention of VF.
Although a cause-and-effect relation between VF initiation and
increased Na+i cannot be conclusively
determined, such a role would be consistent with the data and
with recent reports indicating involvement of
Ca2+i levels.5 6 13 16
Electrogenic Na+-Ca2+ exchange is the
primary sarcolemmal Ca2+ extrusion mechanism, and its
activity exhibits a steep dependence on the Na+
gradient.28 This is imposed by the 3:1 exchange
stoichiometry, which at exchange equilibrium would theoretically
magnify Na+i changes to the third power in
terms of responding Ca2+i changes.
These considerations make it likely that
Ca2+i would increase in response to an
increase in Na+i. Possible mechanisms by which
increased Ca2+i may initiate VF include
induction of triggered activity in the form of afterdepolarizations,
which often precede VF.5 6 Afterdepolarizations may be
triggered by a "transient inward current," reportedly linked to
excess Ca2+i
accumulation.8 9 10 13 Ca2+i
accumulation can induce oscillations in
Ca2+i via spontaneous sarcoplasmic
reticulum Ca2+ release7 and thus
potentiate the inward current by activation of electrogenic
Na+-Ca2+ exchange11 or
nonspecific cation channels.12 The reported antiarrhythmic
effect of inhibiting sarcoplasmic reticulum function with ryanodine
supports such a role for Ca2+i
oscillations.13 16 41 In support of such a
role for Ca2+i overload in
ischemia-induced VF, increases in
Ca2+i have been well documented in
myocardium exposed to zero-flow ischemia or
hypoxia.20 21 22 25 26 27 Low-flow ischemia is
more complex, since with mild coronary flow reductions
insufficient to cause cellular energy depletion (flow, >50% of
control), systolic Ca2+i reportedly
decreases; this could be an important mechanism to downregulate
function and energy consumption.42 However, as flow
reductions become severe and approach zero flow,
Ca2+i increases are likely. Using indo
1 and a 10% flow glucose-perfused rat heart model like the one in the
present study, Camacho et al19 reported increases in
diastolic and systolic
Ca2+i levels in contracting hearts.
Also, the reported high-energy phosphate and pHi changes
were very consistent with those in the present study. The
40% increase in diastolic
Ca2+i reported during 10%
flow19 is similar to the increase reported to precede
spontaneous VF initiated with partial Na+-K+
ATPase inhibition in the ferret heart16 ; it is also
consistent with changes reported for a rat heart before
spontaneous VF.15 Importantly, these moderate pre-VF
elevations of Ca2+i are in a range
consistent with the magnitude of the pre-VF
Na+i changes observed in the present study,
in terms of likely effects from Na+-Ca2+
coupling and exchange.28
In the VF groups, remarkably few arrhythmias were observed during early ischemia, but they were usually observed before the onset of VF. It was found that the time duration between the point the arrhythmias started and that of VF initiation (mean, 8.1±1.4 minutes) correlated significantly (P<.0001) with the Na+i levels 3 minutes before the onset of VF in individual hearts in the combined sham-VF and band-VF groups. Linear regression was used to fit the following function: arrhythmia duration=26 · Na+VF-34 (R2=.56), where Na+VF is the Na+i level 3 minutes before the onset of VF. This correlation is consistent with the concept that Na+i plays a causal role in the induction of arrhythmias that precede and precipitate VF.1 5 6 13 16 Notably, however, Na+ influx during ischemia is not restricted to Na+-H+ exchange, because continued depolarization and contraction ensures a contribution via voltage-activated Na+ channels. The magnitude depends on conditions such as the pacing rate, and the presence of ventricular extrasystoles could potentially accelerate Na+i accumulation itself. In this context, it is important to note that the 20-minute ischemia time point not only preceded all VF, but in sham-VF, it also preceded the development of all arrhythmias in most cases. When the one exception was excluded, the remaining (n=9) sham-VF hearts still exhibited higher Na+i at 20 minutes than did sham-C (P=.01) and sham-HMA (P<.0001) hearts. Consistent with the effects observed with Na+-H+ exchange inhibition, this suggests that the excess Na+i accumulation preceding VF is related to more than simply the presence of extrasystoles and is likely to be more than just a marker for the arrhythmias that lead to VF. A more interactive role for Na+i would be consistent with the data.
Metabolic Alterations After VF
The Na+i versus time from VF data shown in
Fig 8
indicate that at a time coinciding with VF initiation, the slopes
changed by an order of magnitude. This indicates a dramatic increase in
net Na+ influx to rates far exceeding those normally
observed during zero-flow ischemia.23 This is
consistent with reports that ventricular cells are
rapidly excited at the onset of VF, with substantial fast channel
(voltage-activated Na+ channel) activity occurring
during its early stages.43 44 The
Na+i increases and associated alterations of
Na+-Ca2+ exchange28 are
more than adequate to explain the fivefold increases in
Ca2+i reported by Koretsune and
Marban,14 which occurred within 5 to 10 minutes of VF
initiation. Other studies have also reported extraordinary increases in
Ca2+i after VF, occurring on the same
time scale as the Na+i changes in the
present study,15 16 suggesting that
Na+i is an important factor to be considered in
the acceleration and maintenance of the
Ca2+i overload and hence VF itself. The
cellular energy and pHi changes may also be accelerated by
the Na+i overload. Increased
Na+i increases energy demand by stimulating
Na+,K+-ATPase activity.45
Accompanying increases in Ca2+i would
also increase energy demand via contractile apparatus
activation, consistent with the post-VF increase in
diastolic tension observed in the present study. The
post-VF pHi decreases in the present study may also be
related to Ca2+i, because
increases in Ca2+i reportedly depress
pHi.46 Severe Ca2+ overload
can result in mitochondrial Ca2+ accumulation and
thus decrease energy production, which is already slowed during
low-flow ischemia.47 Such an effect could promote
cycles of further metabolic deterioration by slowing
Na+,K+-ATPase activity and thus
increasing Na+i further. Consistent
with this, both increased energy utilization and decreased energy
production have been reported during VF initiated via partial
Na+,K+-ATPase inhibition.48
Severe Ca2+i overload and cellular
energy depletion also occurred.16 18 48 With VF initiated
with electrical burst pacing, Ca2+i
overload is of lesser severity, minimal energy depletion occurs, and in
contrast to the other model, spontaneous defibrillation often
occurs.14 16 48 With either model, effective
defibrillation occurs with low Ca2+
perfusion.41 In combination with the present findings,
these results are consistent with the hypothesis that VF is
maintained, in part, by an inability to regain control of ion
homeostasis because of compromised energy production and/or
Na+,K+-ATPase activity.
The general association of Na+i accumulation
and VF is consistent with a previous study that investigated
hypoxia-induced contractile failure in the perfused rat
heart.49 However, the previous report implied that most of
the increase in Na+i occurred well before the
onset of contractile failure/VF. In contrast, the present study
indicates that severe Na+i overload occurred
only after VF initiation, a pattern that tracks reported
Ca2+i changes with spontaneous
VF.15 16 A large Na+i increase
preceding VF might then imply a decoupling of the
Na+i and Ca2+i
time courses. These apparent differences may be related to the
different hypoxic and ischemic VF models but may also be
related to the difficulty of direct data comparison. Different
23Na NMR shift reagent methodology was used, and the
previous report did not plot data versus the time from VF. The
Na+i increase before the mean time of VF may
have been largely attributable to hearts already in VF, as is clearly
the case in the present study (see Figs 5
and 8
, and mean times of
VF initiation). Although in the previous study the
parameters curve-fitted to the pre-VF
Na+i data indicated a divergent time course,
the magnitude of the pre-VF Na+i changes was
not indicated.
Functional and Metabolic Alterations During
Reperfusion
Functional recovery was delayed for the VF groups, and end
reperfusion ATP was also lower compared with the contracting groups,
indicating greater metabolic injury. However, a complete
reperfusion functional recovery was observed in all groups, which is
consistent with other studies using low-flow ischemia
in perfused rat hearts supplied with glucose.23 27 50 That
the restart of contraction during reperfusion coincided closely in time
with VF termination was strongly suggested by the functional and
electrogram data. Hence, the observed correlation between the
reperfusion recovery times for Na+i
(TNa+) and function (Tfunc), as well as
the association of VF initiation during ischemia, and
termination during reperfusion with a similar
Na+i elevation, are consistent with a
role for Na+i in VF initiation and
maintenance. The data suggest that the recovery of
Na+i and Ca2+i
levels during reperfusion, enabled by the reactivation of energy
production and Na+,K+-ATPase
activity, is likely to be an important factor in the termination of VF
during reperfusion. This would be consistent with observations
in hearts that defibrillated spontaneously16 or with
lidocaine infusion14 15 ;
Ca2+i levels were observed to rapidly
approach control levels before or at the time of conversion to sinus
rhythm.
In the present study, a stimulation in reperfusion lactate efflux was observed in sham- and band-VF compared with sham- and band-C groups. This could be related to the greater ion imbalance in the VF groups, given the reported role for glycolytic energy production in ion homeostasis51 and reperfusion Ca2+i recovery.52 Alternatively, the observations could to some degree be related to the occurrence of poorly perfused regions in the VF hearts, perhaps related to the gradual increases in diastolic tension/left ventricular balloon pressure that occurred after VF. Notably, however, these increases were relatively moderate, and the high ischemic flow rates maintained in this crystalloid-perfused low-flow model should ensure a minimum of vascular washout throughout the tissue. Also, the pHi-sensitive Pi resonance frequency normally indicates the presence of regional infarcts or perfusion heterogeneity by indicating multiple shift (pHi) components53 ; this was not observed in the experiments at any time, and all hearts exhibited an excellent functional recovery. This suggests that tissue perfusion and the various metabolic parameters are not likely to vary to any great extent across the preparation.
Increased Susceptibility of Hypertrophied Hearts to
VF
The increased susceptibility of the band hearts to
ischemia-induced VF is consistent with previous
reports,2 3 but the present study is the first to
document increased VF in hypertrophied myocardium in a
globally ischemic model that normalized vascular differences by
using the same ischemic flow per gram heart weight.
Consistent with other studies in normal and hypertrophied rat
heart models,2 3 heart weight parameters were
not consistently associated with VF incidence. Band hearts were
large, but neither the dry weight nor dry weighttobody weight ratio
differed significantly between subgroups of sham or band or were
predictive of VF within sham or band. Band hearts did have a lower
high-energy phosphate reserve compared with sham hearts, the origin of
which is potentially complex. In the context of the similarity of the
ischemic lactate production and identical flow/oxygen
delivery per gram tissue, the altered energy reserve could increase the
probability of band hearts reaching a critical energy-depleted
metabolic state during ischemia, sufficient to
permit excess cation accumulation. However, control levels of
phosphorus metabolites were similar between subgroups of sham or band
and were not predictive of VF within sham or band. In some studies,
reduced Na+,K+-ATPase activity in models
of myocardial hypertrophy has been
reported,54 55 although not in the aortic-banded
models.56 The present study contains no evidence for a
difference in inherent Na+ efflux capacity in band hearts.
Also, the present study cannot address the possibility that altered
electrophysiological parameters could
play a role in increased VF susceptibility in band
hearts.4
In summary, the present study demonstrated that initiation of ischemia-induced VF was consistently preceded by a moderate degree of excess Na+i accumulation, the prevention of which also prevented VF. This deterioration in Na+i homeostasis may be coupled with the cellular energy state under normal conditions. However, increased cellular energy depletion preceding VF was not consistently observed. The present study is consistent with a causal role for excess Na+i accumulation in VF initiation. Furthermore, the severe Na+i overload that progressed rapidly after VF initiation strongly argues an important role for Na+i in VF maintenance and the associated deterioration of cellular energy. The association between Na+i and VF was further strengthened by a correlation between the reperfusion Na+i and contractile recoveries. Given the likely coupling of Na+i and Ca2+i homeostasis and the previous reports linking Ca2+i and VF, the present study provides new and important information regarding the metabolic deterioration leading to and sustaining ischemia-induced VF.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received February 17, 1995; accepted April 21, 1995.
| References |
|---|
|
|
|---|
2. Kohya T, Kimura S, Myerburg RJ, Basset AL. Susceptibility of hypertrophied rat hearts to ventricular fibrillation during acute ischemia. J Mol Cell Cardiol. 1988;20:159-168. [Medline] [Order article via Infotrieve]
3.
Robertson E, Hof RP, Zierhut W. Effect of
hypertrophy induced by pressure overload or volume overload
on reperfusion induced arrhythmias in anaesthetized
rats. Cardiovasc Res. 1993;27:515-519.
4.
Kowey PR, Friehling TD, Sewter J, Wu Y, Sokil A, Paul
J, Nocella J. Electrophysiological effects
of left ventricular hypertrophy: effect of
calcium and potassium channel blockade.
Circulation. 1991;83:2067-2075.
5. Wit AL, Rosen MR. Afterdepolarization and triggered activity. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System. New York, NY: Raven Press Publishers; 1986:1449-1490.
6. Clusin WT, Buchbinder M, Harrison DC. Calcium overload, `injury current,' and early ischaemic cardiac arrhythmias: a direct connection. Lancet. 1983;1:272-273. [Medline] [Order article via Infotrieve]
7. Orchard CH, Eisner DA, Allen DG. Oscillations of intracellular Ca2+ in mammalian cardiac muscle. Nature. 1983;304:735-738. [Medline] [Order article via Infotrieve]
8.
Lederer WJ, Tsien RW. Transient inward current
underlying arrhythmogenic effects of cardiotonic steroids in Purkinje
fibers. J Physiol (Lond). 1976;263:73-100.
9.
Kass RS, Lederer WJ, Tsien RW, Weingart R. Role
of calcium ions in transient inward currents and aftercontractions
induced by strophanthidin in cardiac purkinje fibers. J
Physiol (Lond). 1978;281:187-208.
10.
Kass RS, Tsien RW, Weingart R. Ionic basis of
transient inward current induced by strophanthidin in cardiac Purkinje
fibers. J Physiol (Lond). 1978;281:209-226.
11.
Fedida D, Noble D, Rankin AC, Spindler AJ. The
arrhythmogenic transient inward current
iT1, and related contraction in isolated
guinea-pig ventricular myocytes. J
Physiol (Lond). 1987;392:523-542.
12. Colquhoun D, Neher E, Reuter H, Stevens CF. Inward current channels activated by intracellular Ca in cultured cells. Nature. 1981;294:752-754. [Medline] [Order article via Infotrieve]
13.
Thandroyen FT, Morris AC, Hagler HK, Ziman B, Pai L,
Willerson JT, Buja LM. Intracellular calcium transients and
arrhythmia in isolated heart cells.
Circ Res. 1991;69:810-819.
14.
Koretsune Y, Marban E. Cell calcium in the
pathophysiology of ventricular fibrillation and in the
pathogenesis of postarrhythmic contractile dysfunction.
Circulation. 1989;80:369-379.
15. Stefenelli T, Wikman-Coffelt J, Shao T, Wu ST, Parmley WW. Intracellular calcium during pacing-induced ventricular fibrillation. J Electrocardiol. 1992;25:221-228. [Medline] [Order article via Infotrieve]
16.
Kihara Y, Morgan JP. Intracellular calcium and
ventricular fibrillation: studies in the aequorin-loaded
isovolumic ferret heart. Circ Res. 1991;68:1378-1389.
17. Grover FL, Fewel JG, Ghidoni JJ, Norton JB, Arom KV, Trinkle JK. Effects of ventricular fibrillation on coronary blood flow and myocardial metabolism. J Thorac Cardiovasc Surg. 1977;73:616-624. [Abstract]
18.
Kusuoka H, Jacobus WE, Marban E. Calcium
oscillations in digitalis-induced ventricular
fibrillation: pathogenic role and metabolic consequences in
isolated ferret hearts. Circ Res. 1988;62:609-619.
19.
Camacho SA, Figueredo VM, Brandes R, Weiner MW.
Ca2+ dependent fluorescence
transients and phosphate metabolism during low-flow
ischemia in rat hearts. Am J Physiol. 1993;265:H114-H122.
20.
Marban E, Kitakaze M, Koretsune Y, Yue DT, Chacko VP,
Pike MM. Quantification of Ca2+i
in perfused hearts: critical evaluation of the 5F-BAPTA and nuclear
magnetic resonance method as applied to the study of ischemia
and reperfusion. Circ Res. 1990;66:1255-1267.
21. Kihara Y, Grossman W, Morgan JP. Direct measurement of changes in intracellular calcium transients during hypoxia, ischemia, and reperfusion of the intact mammalian heart. Circ Res. 1989;65(suppl 4):1029-1044.
22.
Lee H, Mohabir R, Smith N, Franz M, Clusin W.
Effect of ischemia on calcium-dependent
fluorescence transients in rabbit hearts containing indo 1
correlation with monophasic action potentials and contraction.
Circulation. 1988;78:1047-1059.
23.
Pike MM, Luo CS, Clark MD, Kirk KA, Kitakaze M, Madden
MC, Cragoe EJ Jr, Pohost GM. NMR measurements of Na+
and cellular energy in the ischemic rat heart: role of
Na+/H+ exchange. Am J
Physiol. 1993;265:H2017-H2026.
24.
Pike MM, Kitakaze M, Marban E. 23Na
NMR measurement of intracellular Na+ in intact perfused
ferret hearts during ischemia and reperfusion. Am
J Physiol. 1990;259:H1767-H1773.
25.
Murphy E, Perlman M, London RE, Steenbergen C.
Amiloride delays the ischemia-induced rise in cytosolic
free calcium. Circ Res. 1991;68:1250-1258.
26.
Tani M, Neel JR. Role of intracellular
Na+ in Ca2+ overload and depressed
recovery of ventricular function of reperfused
ischemic rat hearts: possible involvement of
Na+/H+ and
Na+/Ca2+ exchange.
Circ Res. 1989;65:1045-1056.
27. Tani M, Neely JR. Na+ accumulation increases Ca2+ overload and impairs function in anoxic rat heart. J Mol Cell Cardiol. 1990;22:57-72. [Medline] [Order article via Infotrieve]
28. Sheu S, Blaustein MP. Sodium/calcium exchange and regulation of cell calcium and contractility in cardiac muscle, with a note about vascular smooth muscle. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System. New York, NY: Raven Press Publishers; 1986:509-535.
29. Lazdunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol. 1985;17:1029-1042. [Medline] [Order article via Infotrieve]
30. Buster CD, Castro MMCA, Geraldes CFGC, Malloy CR, Sherry AD, Seimers TC. Tm(DOTP)5-: a 23Na+ shift agent for perfused rat hearts. Magn Reson Med. 1990;15:25-32. [Medline] [Order article via Infotrieve]
31.
Sako EY, Kingsley-Hickman PB, From AHI, Foker JE,
Ugurbil K. ATP synthesis kinetics and mitochondrial function in
the post-ischemic myocardium as studied by
31P NMR. J Biol Chem. 1988;263:10600-10607.
32. Becker ED, Ferretti JA, Gambhir PN. Selection of optimum parameters for pulse Fourier transform nuclear magnetic resonance. Anal Chem. 1979;51:1413-1420.
33. Jacobus WE, Pores IH, Lucas SK, Kallman CH, Weisfeldt ML, Flaherty JT. The role of intracellular pH in the control of normal and ischemic myocardial contractility: a 31P nuclear magnetic resonance and mass spectrometry study. In: Nuccitelli R, Deamer D, eds. Intracellular pH: Its Measurement, Regulation and Utilization in Cellular Functions. New York, NY: Alan R Liss Inc; 1982:537-565.
34.
Yasutake M, Ibuki C, Hearse DJ, Avkiran M.
Na+/H+ exchange and reperfusion
arrhythmias: protection by intracoronary infusion of a
novel inhibitor. Am J Physiol. 1994;267:H2430-H2440.
35. Chu SCK, Xu Y, Balschi JA, Springer CS. Bulk magnetic susceptibility shifts in NMR studies of compartmentalized samples: use of paramagnetic reagents. Magn Reson Med. 1990;13:239-262. [Medline] [Order article via Infotrieve]
36. Fiolet JWT, Baartscheer A, Schumacher CA, Coronel R, ter Welle HF. The change of the free energy of ATP hydrolysis during global ischemia and anoxia in the rat heart. J Mol Cell Cardiol. 1984;16:1023-1036. [Medline] [Order article via Infotrieve]
37. Kleyman TR, Cragoe EJ. Amiloride and its analogs as tool in the study of ion transport. J Membr Biol. 1988;105:1-21. [Medline] [Order article via Infotrieve]
38. Imai S, Shi A-Y, Ishibashi T, Nakazawa M. Na+/H+ exchange is not operative under low-flow ischemic conditions. J Mol Cell Cardiol. 1991;23:505-517. [Medline] [Order article via Infotrieve]
39. Khandoudi N, Bernard M, Cozzone P, Feuvray D. Intracellular pH and role of Na+/H+ exchange during ischaemia and reperfusion of normal and diabetic rat hearts. Cardiovasc Res. 1990;24:873-878. [Medline] [Order article via Infotrieve]
40.
Vandenberg JI, Metcalfe JC, Grace AA. Mechanisms
of intracellular pH recovery after global ischemia in the
perfused heart. Circ Res. 1993;72:993-1003.
41.
Merillat JC, Lakatta EG, Hano O, Guarnieri T.
Role of calcium and the calcium channel in the initiation and
maintenance of ventricular fibrillation.
Circ Res. 1990;67:1115-1123.
42.
Kitakaze M, Marban E. Cellular mechanism of the
modulation of contractile function by coronary perfusion
pressure in ferret hearts. J Physiol
(Lond). 1989;414:455-472.
43.
Zhou X, Guse P, Wolf PD, Rollins DL, Smith WM, Ideker
RE. Existence of both fast and slow channel activity during the
early stages of ventricular fibrillation.
Circ Res. 1992;70:773-786.
44. Akiyama T. Intracellular recording of in situ ventricular cells during ventricular fibrillation. Am J Physiol. 1981;240:H465-H471.
45. Robinson JD, Flashner MS. The (Na++K+)-activated ATPase: enzymatic and transport properties. Biochim Biophys Acta. 1979;549:145-176. [Medline] [Order article via Infotrieve]
46.
Kim D, Cragoe EJ, Smith TW. Relations among
sodium pump inhibition, Na-Ca and Na-H exchange activities, and Ca-H
interaction in cultured chick heart cells. Circ
Res. 1988;60:185-193.
47. McCormack JG, Denton RM. Ca2+ ions as a link between functional demands and mitochondrial metabolism in the heart. In: Rupp H, ed. The Regulation of Heart Function: Basic Concepts and Clinical Applications. New York, NY: Thieme Medical Publishers Inc; 1986:186-200.
48.
Kusuoka H, Chacko VP, Marban E. Myocardial
energetics during ventricular fibrillation investigated by
magnetization transfer nuclear magnetic resonance spectroscopy.
Circ Res. 1992;71:1111-1122.
49.
Neubauer S, Newell JB, Ingwall JS.
Metabolic consequences and predictability of
ventricular fibrillation in hypoxia: a
31P- and 23Na-nuclear magnetic resonance study
of the isolated rat heart. Circulation. 1992;86:302-310.
50.
Tani M, Neely JR. Vascular washout reduces
Ca2+ overload and improves function of reperfused
ischemic hearts. Am J Physiol. 1990;258:H354-H361.
51. Weiss J, Hiltbrand B. Functional compartmentation of glycolytic versus oxidative metabolism in isolated rabbit heart. J Clin Invest. 1985;75:436-447.
52.
Jeremy RW, Koretsune Y, Marban E, Becker LC.
Relation between glycolysis and calcium homeostasis in
postischemic myocardium.
Circ Res. 1992;70:1180-1190.
53. Bailey IA, Seymour AL, Radda GK. A 31P NMR study of the effects of reflow on the ischemic rat heart. Biochim Biophys Acta. 1981;637:1-7. [Medline] [Order article via Infotrieve]
54.
Lee SW, Schwartz A, Adams RJ, Yamori Y, Whitmer K, Lane
LK, Wallick ET. Decrease in
Na+/K+ ATPase activity and
[3H]ouabain binding sites in sarcolemma prepared from
hearts of spontaneously hypertensive rats.
Hypertension. 1983;5:682-688.
55. Whitmer KR, Lee JH, Martin AF, Lane LK, Lee SW, Schwartz A, Overbeck HW, Wallick ET. Myocardial Na, K-ATPase in one-kidney, one-clip hypertensive rats. J Mol Cell Cardiol. 1986;18:1085-1095. [Medline] [Order article via Infotrieve]
56. Hanf R, Drubaix I, Marotte F, Leleivre LG. Rat cardiac hypertrophy: altered sodium-calcium exchange activity in sarcolemmal vesicles. FEBS Lett. 1988;236:145-149.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
K. Zerumsky and B. F. McBride Ranolazine in the management of chronic stable angina Am. J. Health Syst. Pharm., December 1, 2006; 63(23): 2331 - 2338. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Davies, S. B. Digerness, S. P. Goldberg, C. R. Killingsworth, C. R. Katholi, P. S. Brookes, and W. L. Holman Intra-myocyte ion homeostasis during ischemia-reperfusion injury: effects of pharmacologic preconditioning and controlled reperfusion Ann. Thorac. Surg., October 1, 2003; 76(4): 1252 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I Bak and J. S Ingwall Contribution of Na+/H+ exchange to Na+ overload in the ischemic hypertrophied hyperthyroid rat heart Cardiovasc Res, March 15, 2003; 57(4): 1004 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-r. Wann, M. H. Weil, S. Sun, W. Tang, and T. Yu Cariporide for Pharmacologic Defibrillation After Prolonged Cardiac Arrest Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2002; 7(3): 161 - 169. [Abstract] [PDF] |
||||
![]() |
L. Dai, P. S. Brookes, V. M. Darley-Usmar, and P. G. Anderson Bioenergetics in cardiac hypertrophy: mitochondrial respiration as a pathological target of NO{middle dot} Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2261 - H2269. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Meszaros, D. Khananshvili, and G. Hart Mechanisms underlying delayed afterdepolarizations in hypertrophied left ventricular myocytes of rats Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H903 - H914. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Gazmuri, I. M. Ayoub, E. Hoffner, and J. D. Kolarova Successful Ventricular Defibrillation by the Selective Sodium-Hydrogen Exchanger Isoform-1 Inhibitor Cariporide Circulation, July 10, 2001; 104(2): 234 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Imahashi, H. Kusuoka, K. Hashimoto, J. Yoshioka, H. Yamaguchi, and T. Nishimura Intracellular Sodium Accumulation During Ischemia as the Substrate for Reperfusion Injury Circ. Res., June 25, 1999; 84(12): 1401 - 1406. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. D. Schepkin, I. O. Choy, and T. F. Budinger Sodium alterations in isolated rat heart during cardioplegic arrest J Appl Physiol, December 1, 1996; 81(6): 2696 - 2702. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yanagida, C.S. Luo, M. Doyle, G.M. Pohost, and M.M. Pike Nuclear Magnetic Resonance Studies of Cationic and Energetic Alterations With Oxidant Stress in the Perfused Heart : Modulation With Pyruvate and Lactate Circ. Res., October 1, 1995; 77(4): 773 - 783. [Abstract] [Full Text] |
||||
![]() |
K. Imahashi, T. Nishimura, J. Yoshioka, and H. Kusuoka Role of Intracellular Na+ Kinetics in Preconditioned Rat Heart Circ. Res., June 8, 2001; 88(11): 1176 - 1182. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |